Physical Activity to Mitigate PreEclampsia Risk
PAMPER
1 other identifier
interventional
224
1 country
1
Brief Summary
The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will decrease severity and occurrence of preeclampsia symptoms, thus improving maternal, pregnancy, and birth outcomes. Aim 1. Determine the influence of different exercise modes during pregnancy at risk of preeclampsia on maternal cardiometabolic health. Aim 2. Determine the most effective exercise mode in pregnancy at risk of preeclampsia on improving birth and infant health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2024
CompletedFirst Posted
Study publicly available on registry
March 19, 2024
CompletedStudy Start
First participant enrolled
June 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedJuly 1, 2024
June 1, 2024
1.8 years
March 12, 2024
June 28, 2024
Conditions
Outcome Measures
Primary Outcomes (11)
Systolic Blood Pressure (16wks)
resting SBP
16 weeks gestation
Systolic Blood Pressure (20wks)
resting SBP
20 weeks gestation
Systolic Blood Pressure (24wks)
resting SBP
24 weeks gestation
Systolic Blood Pressure (28wks)
resting SBP
28 weeks gestation
Systolic Blood Pressure (32wks)
resting SBP
32 weeks gestation
Systolic Blood Pressure (36wks)
resting SBP
36 weeks gestation
Maternal Cardiometabolic Risk (CMR) Score
summation of age- and sexstandardized z-scores for waist circumference (or BMI), triglycerides, systolic blood pressure (SBP), glucose (insulin or HOMA-IR), and inverse HDL, with a lower CMR score indicating lower risk
during pregnancy
Symptom Occurrence
maternal medical record and questionnaire data for occurrence, signs, and symptoms of hypertension/pre-eclampsia
at delivery
Placental Efficiency
placental weight gain and birth weight will be used to calculate placental efficiency
at delivery
Birth Weight
infant birth weight
at delivery
Infant Cardiometabolic Risk (CMR) Score
The CMR score will be a summation of age- and sex-standardized z-scores for abdominal circumference (or BMI),systolic blood pressure (SBP), glucose, and inverse HDL, with a lower CMR score indicating lower risk.
at delivery
Secondary Outcomes (53)
Maternal Heart Rate (16wks)
16 weeks gestation
Maternal Heart Rate (20wks)
20 weeks gestation
Maternal Heart Rate (24wks)
24 weeks gestation
Maternal Heart Rate (28wks)
28 weeks gestation
Maternal Heart Rate (32wks)
32 weeks gestation
- +48 more secondary outcomes
Study Arms (4)
AE Group
EXPERIMENTALThe AE group will exercise on aerobic machines (i.e. treadmill, elliptical, bicycle) All exercise participants will be prescribed exercise that meets guidelines of the American College of Obstetricians and Gynecologists (ACOG), American College of Sports Medicine (ACSM), and the American Heart Association (AHA); 150 minutes per week, moderate intensity (60-80% aerobic capacity, Rating of Perceived Exertion, RPE, 12-15) per week. These limits are the same as those that generated previous positive findings for our preliminary data.
RE Group
EXPERIMENTALThe RE group will perform 12-15 repetitions of 10-12 resistance exercises in a circuit, for 3 sets, with a rest period of 30-60 seconds between sets as needed.\[172\] Seated isokinetic exercise using resistance machines will target all major muscle groups. Light dumbbells and resistance bands will be used if the participant is unable to lift the minimal load on machines. Core exercises will be performed at the end of the session (i.e. seated side bends) All exercise participants will be prescribed exercise that meets guidelines of the American College of Obstetricians and Gynecologists (ACOG), American College of Sports Medicine (ACSM), and the American Heart Association (AHA); 150 minutes per week, moderate intensity (60-80% aerobic capacity, Rating of Perceived Exertion, RPE, 12-15) per week. These limits are the same as those that generated previous positive findings for our preliminary data.
AERE Group
EXPERIMENTALAERE group will alternate between AE exercise and RE; for this group, RE exercises will consist of 1 set of 12-15 repetitions of 4 resistance exercises, then 5 minutes of AE, then repeat this cycle with different exercises. All exercise participants will be prescribed exercise that meets guidelines of the American College of Obstetricians and Gynecologists (ACOG), American College of Sports Medicine (ACSM), and the American Heart Association (AHA); 150 minutes per week, moderate intensity (60-80% aerobic capacity, Rating of Perceived Exertion, RPE, 12-15) per week. These limits are the same as those that generated previous positive findings for our preliminary data.
Control
NO INTERVENTIONThe Control group will participate in weekly sessions that focus on stretching, breathing, and healthy lifestyle.
Interventions
Moderate intensity aerobic exercise Moderate intensity resistance exercise Moderate intensity combination exercise
Eligibility Criteria
You may qualify if:
- healthy women, age 18-40 years, \<16 weeks' gestation, with singleton pregnancy; women (BMI:18.5-45.0), sedentary, cleared by their obstetric provider.
You may not qualify if:
- pre-existing chronic conditions such as HIV, lupus, etc.; taking medicines that affect fetal development; and/or lack of telephone or email contact information).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
East Carolina University
Greenville, North Carolina, 27834, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda E May, MS, PhD
East Carolina University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 12, 2024
First Posted
March 19, 2024
Study Start
June 24, 2024
Primary Completion
April 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
July 1, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
de-identified data can be shared upon request to researchers